The information provided on EL7.AI is for educational and informational purposes only and does not constitute financial advice.
The information provided on EL7.AI is for educational and informational purposes only and does not constitute financial advice.
Sign in to access this content
Sign InIn a move reflecting the ongoing appetite for healthcare assets among private equity firms, KKR is nearing a deal to acquire medical-device manufacturer Integer Holdings. According to reports from the Wall Street Journal, the firms are in advanced negotiations with a final agreement potentially being reached soon. The acquisition aligns with KKR's broader investment strategy to deepen its footprint within the medical technology and healthcare sectors.
This potential deal surfaces as private equity players seek to deploy capital into resilient industrial sectors. Per market data, KKR shares stood at $102.66 at the close of July 28, 2026, having traded between a day low of $100.57 and a high of $102.95. The move to bring Integer Holdings under the KKR umbrella highlights the firm's focus on high-value manufacturing within the medical device industry.
Traders should watch for the formal announcement regarding the deal's valuation and structure, as price data for Integer Holdings was not available at the time of reporting. From a macro perspective, the Federal Reserve maintained interest rates at 3.75% following its July 29, 2026 meeting, providing a stable interest rate backdrop for large-scale corporate mergers and acquisitions in the near term.